14 Jan 2019

MEDTRONIC SETTLES DOJ CLAIMS LODGED AGAINST ACQUIRED FIRMS FOR $50.9M

  Medtronic has agreed to pay the U.S. Department of Justice $50.9 million to resolve three claims against Covidien and ev3, two companies Medtronic acquired in 2015. One payment is for $13 million and settles the DOJ’s investigation of the STRATIS Registry, which was designed to assess clinical outcomes of Covidien’s

0
07 Jan 2019

MEDTRONIC GETS OK TO STUDY PATIENTS WITH BICUSPID AORTIC VALUES USING COREVALVE EVOLUT TAVR SYSTEM

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for Medtronic to initiate a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who are at low risk of surgical mortality. Medtronic separately received FDA approval for revised commercial

0
03 Jan 2019

IN.PACT ADMIRAL:  MEDTRONIC SHARES FIVE-YEAR DRUG-COATED BALLOON DATA

  Medtronic plc data presented Nov. 12 reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease in the superficial femoral and popliteal arteries. The five-year and final results from the pivotal IN.PACT SFA Trial and one-year all-subjects results from the

0
12 Oct 2018

CYBER ATTACK FEAR LEADS TO MEDTRONIC DISABLING PACEMAKER INTERNET UPDATE

  Medtronic has disabled the internet update functionality of two of its CareLink devices used to program pacemaker implants amid concerns that they may be susceptible to cyberattacks, according to a letter from the medtech giant to healthcare professionals. Vulnerabilities had been identified in the update download process that could allow an individual

0
27 Sep 2018

MEDTRONIC IN $1.6 BILLION DEAL FOR MAZOR ROBOTICS

          Medtronic has picked up the rest of Israel-based Mazor Robotics in a $1.64 billion deal that is to close in Medtronic’s third quarter ending Jan. 25, 2019. The merger was unveiled at the North American Spine Society 2018 Annual Meeting in Los Angeles Sept. 26. The definitive merger deal

0
24 Jun 2018

JUNE VTN REPORT

SURMODICS BUYS EMBOLITECH’S THROMBECTOMY PLATFORM, TECHNOLOGY, ASSETS FOR $5 MILLION Eden Prairie, Minn.-based SurModics has acquired Embolitech’s thrombectomy platform and associated intellectual property in a deal worth $5 million up front, with additional payments based on regulatory milestones. The technology platform acquired May 14 is designed for use in the peripheral

0
03 Apr 2018

APRIL VTN REPORT

  Vein Therapy News    Industry Report     CIGNA PURCHASING EXPRESS SCRIPTS FOR $67B ON HEELS OF CVS-AETNA VERTICAL MERGER Cigna, which failed in an attempt to merge with Anthem last year, is now going to purchase Express Scripts, the country’s largest pharmacy benefit management (PBM) firm, for $67 billion. Cigna

0